FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2075990213> ?p ?o ?g. }

• W2075990213 endingPage "114" @default.
• W2075990213 startingPage "104" @default.
• W2075990213 abstract "The role of major histocompatibility complex expression in cancer prognosis and pathogenesis is contradictory. The aim of the current study was to compare the expression of HLA class I molecules and of oncoproteins that may be sources of peptides presented by HLA class I antigens in non–small-cell lung cancer. For this purpose, the expression of HLA class I antigen and TAP-1 molecule (a transporter in the antigen-processing 1 transport protein) were studied with epidermal growth factor, receptor; c-erbB-2; episialin; wild-type and mutant p53; bcl-2 oncoprotein expression; and angiogenic factor expression (vascular endothelial growth factor and thymidine phosphorylase). The degree of lymphocytic stromal infiltration and of platelet-endothelial cell adhesion molecule–expressing lymphocytes was also studied. A strong association of c-erbB-2 and MUC1 (episialin) expression with HLA class I expression was observed (p = 0.005 and 0.009, respectively). Intense CD31-positive lymphocytic infiltration was also more frequent in HLA class I–positive cases (p = 0.05). Although there was no association of HLA class I expression with survival, loss of the HLA class I expression in MUC1 or c-erbB-2 overexpressing cases conferred a poorer clinical outcome (p = 0.04). Both c-erbB-2 and MUC1 are well-known targets of T-cell–mediated cytotoxicity and cell–cell or cell–matrix adhesion-regulating proteins. The authors provide evidence that the sequence of cell adhesion-disrupting oncoprotein expression, HLA class I induction, and enhanced epitope presentation followed by lymphocytic response is an important pathogenetic three-step sequence of events that define, in part, the clinical outcome in non–small-cell lung cancer." @default.
• W2075990213 created "2016-06-24" @default.
• W2075990213 creator A5001230246 @default.
• W2075990213 creator A5008056301 @default.
• W2075990213 creator A5011496232 @default.
• W2075990213 creator A5026202643 @default.
• W2075990213 creator A5026228151 @default.
• W2075990213 creator A5027807165 @default.
• W2075990213 creator A5059186956 @default.
• W2075990213 creator A5071319458 @default.
• W2075990213 creator A5079633934 @default.
• W2075990213 creator A5084853594 @default.
• W2075990213 creator A5089995475 @default.
• W2075990213 date "2000-01-01" @default.
• W2075990213 modified "2023-09-27" @default.
• W2075990213 title "c-erbB-2 and Episialin Challenge Host Immune Response by HLA Class I Expression in Human Non–Small-Cell Lung Cancer" @default.
• W2075990213 cites W1417369482 @default.
• W2075990213 cites W1910312489 @default.
• W2075990213 cites W1963652627 @default.
• W2075990213 cites W1971589181 @default.
• W2075990213 cites W1972311492 @default.
• W2075990213 cites W1975549289 @default.
• W2075990213 cites W1979397217 @default.
• W2075990213 cites W1980523883 @default.
• W2075990213 cites W1980575358 @default.
• W2075990213 cites W1981754119 @default.
• W2075990213 cites W1998121016 @default.
• W2075990213 cites W2012375478 @default.
• W2075990213 cites W2016124696 @default.
• W2075990213 cites W2022459765 @default.
• W2075990213 cites W2025565642 @default.
• W2075990213 cites W2032162598 @default.
• W2075990213 cites W2035891785 @default.
• W2075990213 cites W2036142151 @default.
• W2075990213 cites W2043711125 @default.
• W2075990213 cites W2044538362 @default.
• W2075990213 cites W2045245707 @default.
• W2075990213 cites W2046435293 @default.
• W2075990213 cites W2052723163 @default.
• W2075990213 cites W2055970438 @default.
• W2075990213 cites W2056780782 @default.
• W2075990213 cites W2061522225 @default.
• W2075990213 cites W2068638580 @default.
• W2075990213 cites W2069040950 @default.
• W2075990213 cites W2069851047 @default.
• W2075990213 cites W2073520179 @default.
• W2075990213 cites W2085800326 @default.
• W2075990213 cites W2095064082 @default.
• W2075990213 cites W2097033067 @default.
• W2075990213 cites W2123524669 @default.
• W2075990213 cites W2155058151 @default.
• W2075990213 cites W2169778726 @default.
• W2075990213 cites W60985570 @default.
• W2075990213 doi "https://doi.org/10.1097/00002371-200001000-00013" @default.
• W2075990213 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10687143" @default.
• W2075990213 hasPublicationYear "2000" @default.
• W2075990213 type Work @default.
• W2075990213 sameAs 2075990213 @default.
• W2075990213 citedByCount "11" @default.
• W2075990213 countsByYear W20759902132013 @default.
• W2075990213 crossrefType "journal-article" @default.
• W2075990213 hasAuthorship W2075990213A5001230246 @default.
• W2075990213 hasAuthorship W2075990213A5008056301 @default.
• W2075990213 hasAuthorship W2075990213A5011496232 @default.
• W2075990213 hasAuthorship W2075990213A5026202643 @default.
• W2075990213 hasAuthorship W2075990213A5026228151 @default.
• W2075990213 hasAuthorship W2075990213A5027807165 @default.
• W2075990213 hasAuthorship W2075990213A5059186956 @default.
• W2075990213 hasAuthorship W2075990213A5071319458 @default.
• W2075990213 hasAuthorship W2075990213A5079633934 @default.
• W2075990213 hasAuthorship W2075990213A5084853594 @default.
• W2075990213 hasAuthorship W2075990213A5089995475 @default.
• W2075990213 hasConcept C147483822 @default.
• W2075990213 hasConcept C170627219 @default.
• W2075990213 hasConcept C188280979 @default.
• W2075990213 hasConcept C203014093 @default.
• W2075990213 hasConcept C207936829 @default.
• W2075990213 hasConcept C502942594 @default.
• W2075990213 hasConcept C86803240 @default.
• W2075990213 hasConceptScore W2075990213C147483822 @default.
• W2075990213 hasConceptScore W2075990213C170627219 @default.
• W2075990213 hasConceptScore W2075990213C188280979 @default.
• W2075990213 hasConceptScore W2075990213C203014093 @default.
• W2075990213 hasConceptScore W2075990213C207936829 @default.
• W2075990213 hasConceptScore W2075990213C502942594 @default.
• W2075990213 hasConceptScore W2075990213C86803240 @default.
• W2075990213 hasIssue "1" @default.
• W2075990213 hasLocation W20759902131 @default.
• W2075990213 hasLocation W20759902132 @default.
• W2075990213 hasOpenAccess W2075990213 @default.
• W2075990213 hasPrimaryLocation W20759902131 @default.
• W2075990213 hasRelatedWork W1971936988 @default.
• W2075990213 hasRelatedWork W1985889214 @default.
• W2075990213 hasRelatedWork W2031508422 @default.
• W2075990213 hasRelatedWork W2035319065 @default.
• W2075990213 hasRelatedWork W2039266996 @default.
• W2075990213 hasRelatedWork W2060941543 @default.
• W2075990213 hasRelatedWork W2061708895 @default.

• next